메뉴 건너뛰기




Volumn 36, Issue 3, 2016, Pages 482-490

Platelet CD40 exacerbates atherosclerosis by transcellular activation of endothelial cells and leukocytes

Author keywords

atherosclerosis; blood platelets; CD40 ligand; immune system; leukocytes

Indexed keywords

CD40 LIGAND; INTERLEUKIN 1BETA; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1; VASCULAR ENDOTHELIAL CADHERIN; APOLIPOPROTEIN E; CD40 ANTIGEN;

EID: 84959453038     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.307074     Document Type: Article
Times cited : (97)

References (54)
  • 1
    • 84867901553 scopus 로고    scopus 로고
    • The causal role of megakaryocyte-platelet hyperactivity in acute coronary syndromes
    • Martin JF, Kristensen SD, Mathur A, Grove EL, Choudry FA, The causal role of megakaryocyte-platelet hyperactivity in acute coronary syndromes. Nat Rev Cardiol 2012 9 658 670. doi: 10.1038/nrcardio.2012.131
    • (2012) Nat Rev Cardiol , vol.9 , pp. 658-670
    • Martin, J.F.1    Kristensen, S.D.2    Mathur, A.3    Grove, E.L.4    Choudry, F.A.5
  • 2
    • 79955706734 scopus 로고    scopus 로고
    • The hemostatic system as a modulator of atherosclerosis
    • Borissoff JI, Spronk HM, ten Cate H, The hemostatic system as a modulator of atherosclerosis. N Engl J Med 2011 364 1746 1760. doi: 10.1056/NEJMra1011670
    • (2011) N Engl J Med , vol.364 , pp. 1746-1760
    • Borissoff, J.I.1    Spronk, H.M.2    Ten Cate, H.3
  • 3
    • 84871505285 scopus 로고    scopus 로고
    • Thrombosis as an intravascular effector of innate immunity
    • Engelmann B, Massberg S, Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 2013 13 34 45. doi: 10.1038/nri3345
    • (2013) Nat Rev Immunol , vol.13 , pp. 34-45
    • Engelmann, B.1    Massberg, S.2
  • 4
    • 80155193100 scopus 로고    scopus 로고
    • Platelets in atherosclerosis
    • Lievens D, von Hundelshausen P, Platelets in atherosclerosis. Thromb Haemost 2011 106 827 838. doi: 10.1160/TH11-08-0592
    • (2011) Thromb Haemost , vol.106 , pp. 827-838
    • Lievens, D.1    Von Hundelshausen, P.2
  • 6
    • 33846118743 scopus 로고    scopus 로고
    • Platelets as immune cells: Bridging inflammation and cardiovascular disease
    • von Hundelshausen P, Weber C, Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res 2007 100 27 40. doi: 10.1161/01.RES.0000252802.25497.b7
    • (2007) Circ Res , vol.100 , pp. 27-40
    • Von Hundelshausen, P.1    Weber, C.2
  • 7
    • 84973495062 scopus 로고    scopus 로고
    • Immune-mediated and lipid-mediated platelet function in atherosclerosis
    • Ahmadsei M, Lievens D, Weber C, von Hundelshausen P, Gerdes N, Immune-mediated and lipid-mediated platelet function in atherosclerosis. Curr Opin Lipidol 2015 26 438 448. doi: 10.1097/MOL.0000000000000212
    • (2015) Curr Opin Lipidol , vol.26 , pp. 438-448
    • Ahmadsei, M.1    Lievens, D.2    Weber, C.3    Von Hundelshausen, P.4    Gerdes, N.5
  • 12
    • 84862837590 scopus 로고    scopus 로고
    • GITR ligand provided by thrombopoietic cells inhibits NK cell antitumor activity
    • Placke T, Salih HR, Kopp HG, GITR ligand provided by thrombopoietic cells inhibits NK cell antitumor activity. J Immunol 2012 189 154 160. doi: 10.4049/jimmunol.1103194
    • (2012) J Immunol , vol.189 , pp. 154-160
    • Placke, T.1    Salih, H.R.2    Kopp, H.G.3
  • 13
    • 0037877918 scopus 로고    scopus 로고
    • CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation
    • Inwald DP, McDowall A, Peters MJ, Callard RE, Klein NJ, CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 2003 92 1041 1048. doi: 10.1161/01.RES.0000070111.98158.6C
    • (2003) Circ Res , vol.92 , pp. 1041-1048
    • Inwald, D.P.1    McDowall, A.2    Peters, M.J.3    Callard, R.E.4    Klein, N.J.5
  • 14
    • 84944681535 scopus 로고    scopus 로고
    • Regulation of atherosclerotic plaque inflammation
    • Bäck M, Weber C, Lutgens E, Regulation of atherosclerotic plaque inflammation. J Intern Med 2015 278 462 482. doi: 10.1111/joim.12367
    • (2015) J Intern Med , vol.278 , pp. 462-482
    • Bäck, M.1    Weber, C.2    Lutgens, E.3
  • 15
    • 70350447306 scopus 로고    scopus 로고
    • The multi-functionality of CD40L and its receptor CD40 in atherosclerosis
    • Lievens D, Eijgelaar WJ, Biessen EA, Daemen MJ, Lutgens E, The multi-functionality of CD40L and its receptor CD40 in atherosclerosis. Thromb Haemost 2009 102 206 214. doi: 10.1160/TH09-01-0029
    • (2009) Thromb Haemost , vol.102 , pp. 206-214
    • Lievens, D.1    Eijgelaar, W.J.2    Biessen, E.A.3    Daemen, M.J.4    Lutgens, E.5
  • 16
    • 2642608661 scopus 로고    scopus 로고
    • Reduction of atherosclerosis in mice by inhibition of CD40 signalling
    • Mach F, Schönbeck U, Sukhova GK, Atkinson E, Libby P, Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 1998 394 200 203. doi: 10.1038/28204
    • (1998) Nature , vol.394 , pp. 200-203
    • Mach, F.1    Schönbeck, U.2    Sukhova, G.K.3    Atkinson, E.4    Libby, P.5
  • 19
    • 77149136451 scopus 로고    scopus 로고
    • Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile
    • Lutgens E, Lievens D, Beckers L, Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile. J Exp Med 2010 207 391 404. doi: 10.1084/jem.20091293
    • (2010) J Exp Med , vol.207 , pp. 391-404
    • Lutgens, E.1    Lievens, D.2    Beckers, L.3
  • 20
  • 21
    • 0036140664 scopus 로고    scopus 로고
    • CD40-CD40L interactions in atherosclerosis
    • Lutgens E, Daemen MJ, CD40-CD40L interactions in atherosclerosis. Trends Cardiovasc Med 2002 12 27 32
    • (2002) Trends Cardiovasc Med , vol.12 , pp. 27-32
    • Lutgens, E.1    Daemen, M.J.2
  • 22
    • 84856686739 scopus 로고    scopus 로고
    • Upregulation of CD40 ligand and enhanced monocyte-platelet aggregate formation are associated with worse clinical outcome after ischaemic stroke
    • Lukasik M, Dworacki G, Kufel-Grabowska J, Watala C, Kozubski W, Upregulation of CD40 ligand and enhanced monocyte-platelet aggregate formation are associated with worse clinical outcome after ischaemic stroke. Thromb Haemost 2012 107 346 355. doi: 10.1160/TH11-05-0345
    • (2012) Thromb Haemost , vol.107 , pp. 346-355
    • Lukasik, M.1    Dworacki, G.2    Kufel-Grabowska, J.3    Watala, C.4    Kozubski, W.5
  • 28
    • 84882797420 scopus 로고    scopus 로고
    • The CD40/CD40L system: A new therapeutic target for disease
    • Zhang B, Wu T, Chen M, Zhou Y, Yi D, Guo R, The CD40/CD40L system: a new therapeutic target for disease. Immunol Lett 2013 153 58 61. doi: 10.1016/j.imlet.2013.07.005
    • (2013) Immunol Lett , vol.153 , pp. 58-61
    • Zhang, B.1    Wu, T.2    Chen, M.3    Zhou, Y.4    Yi, D.5    Guo, R.6
  • 30
    • 24644496796 scopus 로고    scopus 로고
    • The relationship between soluble CD40 ligand levels and Framingham coronary heart disease risk score in healthy volunteers
    • FATE Investigators
    • Verma S, Wang CH, Li SH, Lonn E, Charbonneau F, Title LM, Anderson TJ, FATE Investigators The relationship between soluble CD40 ligand levels and Framingham coronary heart disease risk score in healthy volunteers. Atherosclerosis 2005 182 361 365. doi: 10.1016/j.atherosclerosis.2005.02.019
    • (2005) Atherosclerosis , vol.182 , pp. 361-365
    • Verma, S.1    Wang, C.H.2    Li, S.H.3    Lonn, E.4    Charbonneau, F.5    Title, L.M.6    Anderson, T.J.7
  • 32
    • 33744548144 scopus 로고    scopus 로고
    • Is there more than C-reactive protein and fibrinogen? the prognostic value of soluble CD40 ligand, interleukin-6 and oxidized low-density lipoprotein with respect to coronary and cerebral vascular disease
    • Lobbes MB, Lutgens E, Heeneman S, Cleutjens KB, Kooi ME, van Engelshoven JM, Daemen MJ, Nelemans PJ, Is there more than C-reactive protein and fibrinogen? The prognostic value of soluble CD40 ligand, interleukin-6 and oxidized low-density lipoprotein with respect to coronary and cerebral vascular disease. Atherosclerosis 2006 187 18 25. doi: 10.1016/j.atherosclerosis.2005.11.005
    • (2006) Atherosclerosis , vol.187 , pp. 18-25
    • Lobbes, M.B.1    Lutgens, E.2    Heeneman, S.3    Cleutjens, K.B.4    Kooi, M.E.5    Van Engelshoven, J.M.6    Daemen, M.J.7    Nelemans, P.J.8
  • 33
    • 33750607885 scopus 로고    scopus 로고
    • Influence of pre-Analytical and analytical factors on soluble CD40L measurements
    • Varo N, Nuzzo R, Natal C, Libby P, Schönbeck U, Influence of pre-Analytical and analytical factors on soluble CD40L measurements. Clin Sci (Lond) 2006 111 341 347. doi: 10.1042/CS20060047
    • (2006) Clin Sci (Lond) , vol.111 , pp. 341-347
    • Varo, N.1    Nuzzo, R.2    Natal, C.3    Libby, P.4    Schönbeck, U.5
  • 35
    • 84924126063 scopus 로고    scopus 로고
    • Revisiting the role of sCD40L as an inflammatory biomarker in a clinical model of acute myocardial infarction
    • Lee R, Revisiting the role of sCD40L as an inflammatory biomarker in a clinical model of acute myocardial infarction. Circ Res 2015 116 e26. doi: 10.1161/CIRCRESAHA.114.305930
    • (2015) Circ Res , vol.116 , pp. e26
    • Lee, R.1
  • 36
    • 78549272749 scopus 로고    scopus 로고
    • Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis
    • Lievens D, Zernecke A, Seijkens T, Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. Blood 2010 116 4317 4327. doi: 10.1182/blood-2010-01-261206
    • (2010) Blood , vol.116 , pp. 4317-4327
    • Lievens, D.1    Zernecke, A.2    Seijkens, T.3
  • 38
    • 0033965079 scopus 로고    scopus 로고
    • Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand
    • Kawai T, Andrews D, Colvin RB, Sachs DH, Cosimi AB, Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med 2000 6 114. doi: 10.1038/72162
    • (2000) Nat Med , vol.6 , pp. 114
    • Kawai, T.1    Andrews, D.2    Colvin, R.B.3    Sachs, D.H.4    Cosimi, A.B.5
  • 41
    • 0035883087 scopus 로고    scopus 로고
    • The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40
    • Henn V, Steinbach S, Büchner K, Presek P, Kroczek RA, The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 2001 98 1047 1054
    • (2001) Blood , vol.98 , pp. 1047-1054
    • Henn, V.1    Steinbach, S.2    Büchner, K.3    Presek, P.4    Kroczek, R.A.5
  • 42
    • 81255143017 scopus 로고    scopus 로고
    • Arterial thrombosis-insidious, unpredictable and deadly
    • Jackson SP, Arterial thrombosis-insidious, unpredictable and deadly. Nat Med 2011 17 1423 1436. doi: 10.1038/nm.2515
    • (2011) Nat Med , vol.17 , pp. 1423-1436
    • Jackson, S.P.1
  • 43
    • 0034019601 scopus 로고    scopus 로고
    • Lessons from sudden coronary death: A comprehensive morphological classification scheme for atherosclerotic lesions
    • Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM, Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000 20 1262 1275
    • (2000) Arterioscler Thromb Vasc Biol , vol.20 , pp. 1262-1275
    • Virmani, R.1    Kolodgie, F.D.2    Burke, A.P.3    Farb, A.4    Schwartz, S.M.5
  • 44
    • 59649100859 scopus 로고    scopus 로고
    • Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases
    • van Gils JM, Zwaginga JJ, Hordijk PL, Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases. J Leukoc Biol 2009 85 195 204. doi: 10.1189/jlb.0708400
    • (2009) J Leukoc Biol , vol.85 , pp. 195-204
    • Van Gils, J.M.1    Zwaginga, J.J.2    Hordijk, P.L.3
  • 45
    • 33845334214 scopus 로고    scopus 로고
    • Risk stratification of patients with acute myocardial infarction by quantification of circulating monocyte-platelet aggregates
    • Lippi G, Montagnana M, Salvagno GL, Cicorella N, Degan M, Minuz P, Lechi C, Guidi GC, Risk stratification of patients with acute myocardial infarction by quantification of circulating monocyte-platelet aggregates. Int J Cardiol 2007 115 101 102. doi: 10.1016/j.ijcard.2005.12.017
    • (2007) Int J Cardiol , vol.115 , pp. 101-102
    • Lippi, G.1    Montagnana, M.2    Salvagno, G.L.3    Cicorella, N.4    Degan, M.5    Minuz, P.6    Lechi, C.7    Guidi, G.C.8
  • 46
    • 84877755222 scopus 로고    scopus 로고
    • Pharmacological control of platelet-leukocyte interactions by the human anti-P-selectin antibody inclacumab-preclinical and clinical studies
    • Kling D, Stucki C, Kronenberg S, Tuerck D, Rhéaume E, Tardif JC, Gaudreault J, Schmitt C, Pharmacological control of platelet-leukocyte interactions by the human anti-P-selectin antibody inclacumab-preclinical and clinical studies. Thromb Res 2013 131 401 410. doi: 10.1016/j.thromres.2013.02.020
    • (2013) Thromb Res , vol.131 , pp. 401-410
    • Kling, D.1    Stucki, C.2    Kronenberg, S.3    Tuerck, D.4    Rhéaume, E.5    Tardif, J.C.6    Gaudreault, J.7    Schmitt, C.8
  • 47
    • 84862670355 scopus 로고    scopus 로고
    • An intense and short-lasting burst of neutrophil activation differentiates early acute myocardial infarction from systemic inflammatory syndromes
    • Maugeri N, Rovere-Querini P, Evangelista V, An intense and short-lasting burst of neutrophil activation differentiates early acute myocardial infarction from systemic inflammatory syndromes. PLoS One 2012 7 e39484. doi: 10.1371/journal.pone.0039484
    • (2012) PLoS One , vol.7 , pp. e39484
    • Maugeri, N.1    Rovere-Querini, P.2    Evangelista, V.3
  • 49
    • 0025939394 scopus 로고
    • Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production
    • Hawrylowicz CM, Howells GL, Feldmann M, Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production. J Exp Med 1991 174 785 790
    • (1991) J Exp Med , vol.174 , pp. 785-790
    • Hawrylowicz, C.M.1    Howells, G.L.2    Feldmann, M.3
  • 51
    • 78650420516 scopus 로고    scopus 로고
    • Enhanced levels of soluble CD40 ligand exacerbate platelet aggregation and thrombus formation through a CD40-dependent tumor necrosis factor receptor-Associated factor-2/Rac1/p38 mitogen-Activated protein kinase signaling pathway
    • Yacoub D, Hachem A, Théorêt JF, Gillis MA, Mourad W, Merhi Y, Enhanced levels of soluble CD40 ligand exacerbate platelet aggregation and thrombus formation through a CD40-dependent tumor necrosis factor receptor-Associated factor-2/Rac1/p38 mitogen-Activated protein kinase signaling pathway. Arterioscler Thromb Vasc Biol 2010 30 2424 2433. doi: 10.1161/ATVBAHA.110.216143
    • (2010) Arterioscler Thromb Vasc Biol , vol.30 , pp. 2424-2433
    • Yacoub, D.1    Hachem, A.2    Théorêt, J.F.3    Gillis, M.A.4    Mourad, W.5    Merhi, Y.6
  • 53
    • 84866314973 scopus 로고    scopus 로고
    • A phase 1 study of lucatumumab, a fully human anti-CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma
    • Bensinger W, Maziarz RT, Jagannath S, Spencer A, Durrant S, Becker PS, Ewald B, Bilic S, Rediske J, Baeck J, Stadtmauer EA, A phase 1 study of lucatumumab, a fully human anti-CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma. Br J Haematol 2012 159 58 66. doi: 10.1111/j.1365-2141.2012.09251.x
    • (2012) Br J Haematol , vol.159 , pp. 58-66
    • Bensinger, W.1    Maziarz, R.T.2    Jagannath, S.3    Spencer, A.4    Durrant, S.5    Becker, P.S.6    Ewald, B.7    Bilic, S.8    Rediske, J.9    Baeck, J.10    Stadtmauer, E.A.11


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.